Transfeminine

'Transfeminine' (Dutch: 'transfeminien') is an umbrella term for people assigned male at birth (AMAB) who move in a feminine direction—in identity, expression, social presentation, or medical transition. The label is broader than transgender woman: non-binary AMAB people who move toward the feminine are generally included as well.

What does it mean?

Transfeminine describes a direction, not necessarily an endpoint. Someone can be transfeminine without identifying entirely as a 'woman' or undergoing medical transition. The umbrella includes trans women, some non-binary AMAB people, and people who use estrogen or consider feminizing procedures without identifying as women.

Distinction and overlap

The term overlaps with MTF ('male-to-female'), which is older and more specifically refers to complete transition. Transfeminine is more recent, broader, and includes non-binary pathways. Demigirl can be a specific interpretation of the term.

Social and practical context

Transfeminine pathways involve the usual considerations surrounding hormones and surgery: they are invasive, partly irreversible, and have implications for fertility. Estrogen has significant side effects in adult men; vaginoplasty and facial surgery (FFS) have permanent consequences. In sports and women-specific spaces, the distinction between biological and legal sex plays a role—see gender and sports.

Critical perspectives

AMAB pathways include at least two subgroups: early-onset dysphoria (beginning in childhood) and late-onset dysphoria (after puberty, sometimes initially associated with autogynephilia as described by Blanchard). Both groups have different clinical profiles and outcomes; they are rarely distinguished in current discourse. A thorough differential assessment is essential. That a pathway can also end in regret is illustrated by the story of Walt Heyer, who lived as a woman for eight years after surgery and then detransitioned. It is featured on ikbentrans.nl.